What progress has the industry made in advancing women in leadership, R&D, and clinical roles?

Katrina Rice, Chief Delivery Officer Biometrics Services, eClinical Solutions

Although progress has been made, many roles remain concentrated in support functions or middle management rather than at the core of business operations with profit-and-loss responsibilities; albeit expressing equal ambition to reach top leadership roles. Globally, women make up roughly 30% of researchers yet are vastly underrepresented in senior leadership and higher-paying R&D positions.¹

Studies show that diverse leadership teams challenge antiquated ways and foster innovation – critical qualities in R&D, where creativity and progress are essential. Despite these findings, systemic barriers prevent women from ascending to senior roles including unconscious bias, limited access to sponsorship, and organizational cultures that often favor traditional leadership archetypes.²

This isn’t just about fairness, it’s about competitive advantage.³ Companies that embed diverse perspectives across problem-solving, analysis, communication, and leadership consistently outperform those with homogenous leadership teams.

Now, it’s more important than ever for companies to maintain and expand programs that support advancing women in leadership. Scaling back these initiatives would be a strategic mistake. Instead, organizations should build balanced leadership teams that excel at creative problem-solving and demonstrate greater adaptability in dynamic environments.⁴

The momentum toward equity is real, but true parity in leadership, science, and clinical care will require sustained and deliberate action.

1. Women in Science.

2. Women Leaders in Pharma (2025 Edition): The Work Continues, the Impact Grows.

3. Why Gender Equity in the Workplace is Good for Business.

4. Women in the Workplace 2024: The 10th-anniversary report.